Non-thermal dielectric barrier discharge plasma induces angiogenesis through reactive oxygen species

Journal of the Royal Society Interface

Volumn 9, Issue 66, 2012, Pages 147-157

  Arjunan, Krishna Priya ^a   Friedman, Gary ^b   Fridman, Alexander ^b   Clyne, Alisa Morss ^a,b  

^a DREXEL UNIVERSITY   (United States)

^b Drexel University   (United States)

Author keywords

Angiogenesis; Fibroblast growth factor 2 release; Non thermal plasma; Reactive oxygen species; Vascularization; Wound healing

Indexed keywords

BODY FLUIDS; CELL CULTURE; CELL DEATH; COAGULATION; DIELECTRIC DEVICES; DIELECTRIC LIQUIDS; ECOLOGY; ENDOTHELIAL CELLS; FIBROBLASTS; FLOW CONTROL; MEDICAL APPLICATIONS; OXYGEN; PEPTIDES; PLASMA APPLICATIONS; PLASMA THEORY; TISSUE; TISSUE ENGINEERING;

ANGIOGENESIS; FIBROBLAST GROWTH FACTOR-2 RELEASE; NON-THERMAL PLASMA; REACTIVE OXYGEN SPECIES; VASCULARIZATION; WOUND HEALING;

ELECTRIC DISCHARGES;

FIBROBLAST GROWTH FACTOR 2; REACTIVE OXYGEN METABOLITE;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; ENDOTHELIUM CELL; MEDICAL DEVICE; NON THERMAL DIELECTRIC BARRIER DISCHARGE PLASMA; NONHUMAN; PLASMA GAS; PROTEIN SECRETION; TISSUE ENGINEERING; VASCULARIZATION; WOUND HEALING;

SUS;

EID: 83455174205     PISSN: 17425689     EISSN: 17425662     Source Type: Journal    
DOI: 10.1098/rsif.2011.0220     Document Type: Article

References (112)

1. Folkman, J. 2006 Angiogenesis. Annu. Rev. Med. 57, 1-18. (doi:10.1146/annurev.med.57.121304.131306)
2. Martin, A., Komada, M. R. & Sane, D. C. 2003 Abnormal angiogenesis in diabetes mellitus. Med. Res. Rev. 23, 117-145. (doi:10.1002/med.10024)
3. Mulligan-Kehoe, M. J., Drinane, M. C., Mollmark, J., Casciola-Rosen, L., Hummers, L. K., Hall, A., Rosen, A., Wigley, F. M. & Simons, M. 2007 Antiangiogenic plasma activity in patients with systemic sclerosis. Arthritis Rheum. 56, 3448-3458. (doi:10.1002/art.22861)
4. Reed, M. J., Corsa, A., Pendergrass, W., Penn, P., Sage, E. H. & Abrass, I. B. 1998 Neovascularization in aged mice: delayed angiogenesis is coincident with decreasing levels of transforming growth factor beta1 and type 1 collagen. Am. J. Pathol. 152, 113-123. (Pubitemid 28028052)
5. Schäfer, M. & Werner, S. 2008 Oxidative stress in normal and impaired wound repair. Pharmacol. Res. 58, 165-171. (doi:10.1016/j.phrs.2008.06. 004)
6. Bland, K. I., Palin, W. E., Fraunhofer, J. A. V., Morris, R. R., Adcock, R. A. & Tobin, G. R. 1984 Experimental and clinical observations of the effects of cytotoxic chemotherapeutic drugs on wound healing. Annu. Surg. 199, 782-790. (doi:10.1097/00000658-198406000-00017)
7. Tibbs, M. K. 1997 Wound healing following radiation therapy: a review. Radiother. Oncol. 42, 99-106. (doi:10.1016/s0167-8140(96)01880-4)
8. Shimizu, T., Sekine, H., Yang, J., Isoi, Y., Yamato, M., Kikuchi, A. & Okano, T. 2006 Polysurgery of cell sheet grafts overcomes diffusion limits to produce thick, vascularized myocardial tissues. FASEB J. 20, 708-710. (doi:10.1096/fj.05-4715fje)
9. Lovett, M., Lee, K., Edwards, A. & Kaplan, D. L. 2009 Vascularization strategies for tissue engineering. Tissue Eng. Part B Rev. 15, 353-370. (doi:10.1089/ten.teb.2009.0085)
10. Rouwkema, J., Rivron, N. C. & vanBlitterswijk, C. A. 2008 Vascularizaton in tissue engineering. Trends Biotechnol. 26, 434-441. (doi:10.1016/j.tibtech.2008.04.009)
11. Mikos, A. G. et al. 2006 Engineering complex tissues. Tissue Eng. 12, 3307-3339. (doi:10.1089/ten.2006.12.3307)
12. Ferrara, N., Gerber, H.-P. & LeCouter, J. 2003 The biology of VEGF and its receptors. Nat. Med. 9, 669-676. (doi:10.1038/nm0603-669)
13. Neufeld, G., Cohen, T., Gengrinovitch, S. & Poltorak, Z. 1999 Vascular endothelial growth factor (VEGF) and its receptors. FASEB J. 13, 9-22. (Pubitemid 29038270)
14. Bikfalvi, A., Klein, S., Pintucci, G. & Rifkin, D. B. 1997 Biological roles of fibroblast growth factor-2. Endocr. Rev. 18, 26-45. (doi:10.1210/er.18.1.26)
15. Presta, M., Dell'Era, P., Mitola, S., Moroni, E., Ronca, R. & Rusnati, M. 2005 Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev. 16, 159-178. (doi:10.1016/j.cytogfr.2005.01.004)
16. Passaniti, A., Taylor, R. M., Pili, R., Guo, Y., Long, P. V., Haney, J. A., Pauly, R. R., Grant, D. S. & Martin, G. R. 1992 A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Invest. 67, 519-528.
17. Tong, S. & Yuan, F. 2008 Dose response of angiogenesis to basic fibroblast growth factor in rat corneal pocket assay: I. Experimental characterizations. Microvasc. Res. 75, 10-15. (doi:10.1016/j.mvr.2007.06.002)
18. Jain, R. K., Schlenger, K., Hockel, M. & Yuan, F. 1997 Quantitative angiogenesis assays: progress and problems. Nat. Med. 3, 1203-1208. (doi:10.1038/nm1197-1203)
19. Cano, M., Karagiannis, E. D., Soliman, M., Bakir, B., Zhuang, W., Popel, A. S. & Gehlbach, P. L. 2009 A peptide derived from type 1 thrombospondin repeat-containing protein WISP-1 inhibits corneal and choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 50, 3840-3845. (doi:10.1167/iovs.08-2607)
20. Adya, R., Tan, B. K., Punn, A., Chen, J. & Randeva, H. S. 2008 Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis. Cardiovasc. Res. 78, 356-365. (doi:10.1093/cvr/cvm111)
21. Ma, X., Ottino, P., Bazan, H. E. P. & Bazan, N. G. 2004 Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells. Invest. Ophthalmol. Vis. Sci. 45, 2915-2921. (doi:10.1167/iovs.04-0128)
22. Camussi, G., Montrucchio, G., Lupia, E., De Martino, A., Perona, L., Arese, M., Vercellone, A., Toniolo, A. & Bussolino, F. 1995 Platelet-activating factor directly stimulates in vitro migration of endothelial cells and promotes in vivo angiogenesis by a heparin-dependent mechanism. J. Immunol. 154, 6492-6501.
23. Rau, C., Yang, J. C.-S., Jeng, S.-F., Chen, Y.-C., Lin, C.-J., Wu, C.-J., Lu, T.-H. & Hsieh, C.-H. 2011 Far-infrared radiation promotes angiogenesis in human microvascular endothelial cells via extracellular signal-regulated kinase activation. Photochem. Photobiol. 87, 441-446. (doi:10.1111/j.1751-1097. 2010.00853.x)
24. Kanda, S., Mochizuki, Y. & Kanetake, H. 2003 Stromal cell-derived factor-1α induces tube-like structure formation of endothelial cells through phosphoinositide 3-kinase. J. Biol. Chem. 278, 257-262. (doi:10.1074/jbc.M204771200)
25. Edelman, E. R., Mathiowitz, E., Langer, R. & Klagsbrun, M. 1991 Controlled and modulated release of basic fibroblast growth factor. Biomaterials 12, 619-626. (doi:10.1016/0142-9612(91)90107-L)
26. Borselli, C., Oliviero, O., Battista, S., Ambrosio, L. & Netti, P. A. 2007 Induction of directional sprouting angiogenesis by matrix gradients. J. Biomed. Mater. Res. A 80A, 297-305. (doi:10.1002/jbm.a.30896)
27. Dor, Y., Djonov, V., Abramovitch, R., Itin, A., Fishman, G. I., Carmeliet, P., Goelman, G. & Keshet, E. 2002 Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy. EMBO J. 21, 1939-1947. (doi:10.1093/emboj/21.8.1939)
28. Boodhwani, M., Sodha, N. R., Laham, R. J. & Sellke, F. W. 2006 The future of therapeutic myocardial angiogenesis. SHOCK 26, 332-341. (doi:10.1097/01.shk.0000225318.08681.a7)
29. Robson, M. C., Mustoe, T. A. & Hunt, T. K. 1998 The future of recombinant growth factors in wound healing. Am. J. Surg. 176(Suppl. 2, 1), S80-S82. (doi:10.1016/s0002-9610(98)00186-x)
30. Simons, M. et al. 2000 Clinical trials in coronary angiogenesis: issues, problems, consensus: an expert panel summary. Circulation 102, e73-e86.
31. Cross, M. J. & Claesson-Welsh, L. 2001 FGF and VEGF function in angiogenesis: signaling pathways, biological responses and therapeutic inhibition. Trends Pharmacol. Sci. 22, 201-207. (doi:10.1016/S0165-6147(00) 01676-X)
32. Nugent, M. A. & Iozzo, R. V. 2000 Fibroblast growth factor-2. Int. J. Biochem. Cell Biol. 32, 115-120. (doi:10.1016/S1357-2725(99)00123-5)
33. Houchen, C. W., George, R. J., Sturmoski, M. A. & Cohn, S. M. 1999 FGF-2 enhances intestinal stem cell survival and its expression is induced after radiation injury. Am. J. Physiol. Gastrointest. Liver Physiol. 276, G249-G258. (Pubitemid 29063623)
34. Tepper, O. M. et al. 2004 Electromagnetic fields increase in vitro and in vivo angiogenesis through endothelial release of FGF-2. FASEB J. 18, 1231-1233. (doi:10.1096/fj.03-0847fje)
35. Fuks, Z., Persaud, R. S., Alfieri, A., McLoughlin, M., Ehleiter, D., Schwartz, J. L., Cordon-Cardo, A. P. S. C. & Haimovitz-Friedman, A. 1994 Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Res. 54, 2582-2590. (Pubitemid 24173742)
36. Haimovitz-Friedman, A., Balaban, N., McLoughlin, M., Ehleiter, D., Michaeli, J., Vlodavsky, I. & Fuks, Z. 1994 Protein kinase C mediated basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. Cancer Res. 54, 2591-2597. (Pubitemid 24173743)
37. Morss, A. S. & Edelman, E. R. 2007 Glucose modulates basement membrane fibroblast growth factor-2 via alterations in endothelial cell permeability. J. Biol. Chem. 282, 14 635-14 644. (doi:10.1074/jbc.M608565200)
38. Cheng, G. C., Briggs, W. H., Gerson, D. S., Libby, P., Grodzinsky, A. J., Gray, M. L. & Lee, R. T. 1997 Mechanical strain tightly controls fibroblast growth factor-2 release from cultured human vascular smooth muscle cells. Circ Res. 80, 28-36. (Pubitemid 27030365)
39. Ku, P. T. & D'Amore, P. A. 1995 Regulation of basic fibroblast growth factor (bFGF) Gene and protein expression following its release from sublethally injured endothelial cells. J. Cell Biochem. 58, 328-343. (doi:10.1002/jcb.240580307)
40. Finklestein, S. P., Apostolides, P. J., Caday, C. G., Prosser, J., Philips, M. F. & Klagsbrun, M. 1988 Increased basic fibroblast growth factor (bFGF) immunoreactivity at the site of focal brain wounds. Brain Res. 460, 253-259. (doi:10.1016/0006-8993(88)90370-8)
41. Fischer, T. A. et al. 1997 Regulation of bFGF expression and Ang II secretion in cardiac myocytes and microvascular endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 272, H958-H968.
42. Weich, H. A., Iberg, N., Klagsbrun, M. & Folkman, J. 1991 Transcriptional regulation of basic fibroblast growth factor gene expression in capillary endothelial cells. J. Cell Biochem. 47, 158-164. (doi:10.1002/jcb. 240470209)
43. Jimenez, S. K., Sheikh, F., Jin, Y., Detillieux, K. A., Dhaliwal, J., Kardami, E. & Cattini, P. A. 2004 Transcriptional regulation of FGF-2 gene expression in cardiac myocytes. Cardiovasc.Res. 62, 548-557. (doi:10.1016/j.cardiores.2004.01.032)
44. Seghezzi, G. et al. 1998 Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesis. J. Cell Biol. 141, 1659-1673. (doi:10.1083/jcb.141.7.1659)
45. Kong, M. G., Kroesen, G., Morfill, G., Nosenko, T., Shimizu, T., Dijk, J. v. & Zimmermann, J. L. 2009 Plasma medicine: an introductory review. New J. Phys. 11, 1 15012. (doi:10.1088/1367-2630/11/11/115012)
46. Chirokov, A., Gutsol, A. & Fridman, A. 2005 Atmospheric pressure plasma of dielectric barrier discharges. Pure Appl. Chem. 77, 487-495. (doi:10.1351/pac200577020487)
47. Kalghatgi, S. et al. 2007 Mechanism of blood coagulation by nonthermal atmospheric pressure dielectric barrier discharge plasma. IEEE Trans. Plasma Sci. 35, 1559-1566. (doi:10.1109/TPS.2007.905953)
48. Fridman, G., Peddinghaus, M., Ayan, H., Fridman, A., Balasubramanian, M., Gutsol, A., Brooks, A. & Friedman, G. 2006 Blood coagulation and living tissue sterilization by floating-electrode dielectric barrier discharge in air. Plasma Chem. Plasma Process. 26, 425-442. (doi:10.1007/s11090-006-9024-4)
49. Kuo, S. P. et al. 2009 Contribution of a portable air plasma torch to rapid blood coagulation as a method of preventing bleeding. New J. Phys. 11, 115016. (doi:10.1088/1367-2630/11/11/115016)
50. Raiser, J. & Zenker, M. 2006 Argon plasma coagulation for open surgical and endoscopic applications: state of the art. J. Phys. D: Appl. Phys. 39, 3520-3523. (doi:10.1088/0022-3727/39/16/S10)
51. Shekhter, A. B., Serezhenkov, V. A., Rudenko, T. G., Pekshev, A. V. & Vanin, A. F. 2005 Beneficial effect of gaseous nitric oxide on the healing of skin wounds. Nitric Oxide Biol. Chem. 12, 210-219. (doi:10.1016/j.niox.2005.03. 004)
52. Soloshenko, I. A., Tsiolko, V. V., Khomich, V. A., Shchedrin, A. I., Ryabtsev, A. V., Bazhenov, V. Y. & Mikhno, I. L. 2000 Sterilization of medical products in low-pressure glow discharges. Plasma Phys. Rep. 26, 792-800. (doi:10.1134/1.1309476)
53. Sladek, R. E. J., Stoffels, E., Walraven, R., Tielbeek, P. J. A. & Koolhoven, R. A. 2004 Plasma treatment of dental cavities: a feasibility study. IEEE Trans. Plasma Sci. 32, 1540-1543. (doi:10.1109/TPS.2004.832636)
54. Fridman, G., Friedman, G., Gutsol, A., Shekter, A. B., Vasilets, V. & Fridman, A. 2008 Applied plasma medicine. Plasma Process. Polym. 5, 503-533. (doi:10.1002/ppap.200700154)
55. Sensenig, R. et al. 2010 Non-thermal plasma induces apoptosis in melanoma cells via production of intracellular reactive oxygen species. Ann. Biomed. Eng. 39, 674-687. (doi:10.1007/s10439-010-0197-x)
56. Yildrim, E. D., Ayan, H., Vasilets, V. N., Fridman, A., Guceri, S., Friedman, G. & Sun, W. 2008 Effect of dielectric barrier discharge plasma on the attachment and proliferation of osteoblasts cultured over poly(ε-caprolactone) scaffolds. Plasma Process. Polym. 5, 58-66. (doi:10.1002/ppap.200700041)
57. Eliasson, B., Egli, W. & Kogelschatz, U. 1994 Modelling of dielectric barrier discharge chemistry. Pure Appl. Chem. 66, 1275-1286. (doi:10.1351/pac199466061275)
58. Kuchenbecker, M., Bibinov, N., Kaemlimg, A., Wandke, D., Awakowicz, P. & Viol, W. 2009 Characterization of DBD plasma source for biomedical applications. J. Phys. D: Appl. Phys. 42, 045212. (doi:10.1088/0022-3727/42/4/ 045212)
59. Ushio-Fukai, M. & Alexander, R. W. 2004 Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase. Mol. Cell Biochem. 264, 85-97. (doi:10.1023/B:MCBI.0000044378.09409.b5)
60. Fraticelli, A., Serrano, C., Bochner, B., Capogrossi, M. & Zweier, J. 1996 Hydrogen peroxide and superoxide modulate leukocyte adhesion molecule expression and leukocyte endothelial adhesion. Biochim. Biophys. Acta 1310, 251-259. (doi:10.1016/0167-4889(95)00169-7)
61. Roy, S., Khanna, S., Nallu, K., Hunt, T. K. & Sen, C. K. 2006 Dermal wound healing is subject to redox control. Mol. Ther. 13, 211-220. (doi:10.1016/j.ymthe.2005.07.684)
62. Sen, C. K., Khanna, S., Babior, B. M., Hunt, T. K., Ellison, E. C. & Roy, S. 2002 Oxidant-induced vascular endothelial growth factor expression in human keratinocytes and cutaneous wound healing. J. Biol. Chem. 277, 33 284-33 290. (doi:10.1074/jbc.M203391200)
63. Wlaschek, M. & Scharffetter-Kochanek, K. 2005 Oxidative stress in chronic venous leg ulcers. Wound Repair Regen. 13, 452-461. (doi:10.1111/j.1067- 1927.2005.00065.x)
64. Black, S. M., DeVol, J. M. & Wedgwood, S. 2008 Regulation of fibroblast growth factor-2 expression in pulmonary arterial smooth muscle cells involves increased reactive oxygen species generation. Am J. Physiol. Cell Physiol. 294, C345-C354. (doi:10.1152/ajpcell.00216.2007)
65. Pechan, P. A., Chowdhury, K. & Seifert, W. 1992 Free radicals induce gene expression of NGF and bFGF in rat astrocyte culture. Neuroreport 3, 469-472. (doi:10.1097/00001756-199206000-00003)
66. Eyries, M., Collins, T. & Khachigian, L. M. 2004 Modulation of growth factor gene expression in vascular cells by oxidative stress. Endothelium 11, 133-139. (doi:10.1080/10623320490482691)
67. Delafontaine, P. & Ku, L. 1997 Reactive oxygen species stimulate insulin-like growth factor-1 synthesis in vascular smooth muscle cells. Cardiovasc. Res. 33, 216-222. (doi:10.1016/S0008-6363(96)00179-4)
68. Vivekananda, J., Lin, A., Coalson, J. J. & King, R. J. 1994 Acute inflammatory injury in the lung precipitated by oxidant stress induces fibroblasts to synthesize and release transforming growth factor-α. J. Biol. Chem. 269, 25 057-25 061.
69. Colavitti, R., Pani, G., Bedogni, B., Anzevino, R., Borrello, S., Waltenberger, J. & Galeotti, T. 2002 Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR. J. Biol. Chem. 277, 3101-3108. (doi:10.1074/jbc.M107711200)
70. 2 redox stress. Am. J. Respir. Cell Mol. Biol. 19, 786-798.
71. 2 for vascular smooth muscle cells is mediated by an increase of the affinity of basic fibroblast growth factor for its receptor. FEBS Lett. 395, 43-47. (doi:10.1016/0014-5793(96)00998-2)
72. Martin, K. R. & Barrett, J. C. 2002 Reactive oxygen species as double-edged swords in cellular processes: low-dose cell signaling versus high-dose toxicity. Hum. Exp. Toxicol. 21, 71-75. (doi:10.1191/ 0960327102ht213oa)
73. Witte, L., Fuks, Z., Haimovitz-Friedman, A., Vlodavsky, I., Goodman, D. S. & Eldor, A. 1989 Effects of irradiation on the release of growth factors from cultured bovine, porcine and human endothelial cells. Cancer Res. 49, 5066-5072. (Pubitemid 19239345)
74. Kalghatgi, S., Friedman, G., Fridman, A. & Clyne, A. M. 2010 Endothelial cell proliferation is enhanced by low dose non-thermal plasma through fibroblast growth factor-2 release. Ann. Biomed. Eng. 38, 748-757. (doi:10.1007/s10439-009-9868-x)
75. Wong, M. K. & Gotlieb, A. I. 1984 In vitro reendothelialization of a single-cell wound. Role of microfilament bundles in rapid lamellipodia-mediated wound closure. Lab. Invest. 51, 75-81. (Pubitemid 14053755)
76. Clyne, A. M., Zhu, H. & Edelman, E. R. 2008 Elevated fibroblast growth factor-2 increases tumor necrosis factor-alpha induced endothelial cell death in high glucose. J. Cell Physiol. 217, 86-92. (doi:10.1002/jcp.21476)
77. Fridman, G., Brooks, A., Balasubramanian, M., Fridman, A., Gutsol, A., Vasilets, V., Ayan, H. & Friedman, G. 2007 Comparison of direct and indirect effects of non-thermal atmospheric pressure plasma on bacteria. Plasma Process. Polym. 4, 370-375. (doi:10.1109/PPPS.2007.4345628)
78. Ayan, H., Fridman, G., Staack, D., Gutsol, A. F., Vasilets, V. N., Fridman, A. A. & Friedman, G. 2009 Heating effect of dielectric barrier discharges for direct medical treatment. Plasma Science IEEE Trans. 37, 113-120. (doi:10.1109/TPS.2008.2006899)
79. Bibinov, N., Rajasekaran, P., Mertmann, P., Wandke, D., Viol, W. & Awakowicz, P. 2011 Basics and biomedical applications of dielectric barrier discharge (DBD). In Biomedical engineering, trends in materials science (ed. A. N. Laskovski). Rijeka, Croatia: InTech.
80. Morfill, G. E., Kong, M. G. & Zimmermann, J. L. 2009 Focus on plasma medicine. New J. Phys. 11, 1 15011. (doi:10.1088/1367-2630/11/11/115011)
81. Ferrer, A. S., Santema, J., Hilhorst, R. & Visser, A. 1990 Fluorescence detection of enzymatically formed hydrogen peroxide in aqueous solution and in reversed micelles. Anal. Biochem. 187, 129-132. (doi:10.1016/0003-2697(90)90429-D)
82. LeBel, C. P., Ischiropoulos, H. & Bondy, S. C. 1992 Evaluation of the probe 2′,7′-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem. Res. Toxicol. 5, 227-231. (doi:10.1021/tx00026a012)
83. Cathcart, R., Schwiers, E. & Ames, B. N. 1983 Detection of picomoles of hydroperoxides using a fluorescence dichlorofluorescein assay. Anal. Biochem. 134, 111-116. (doi:10.1016/0003-2697(83)90270-1)
84. Dixit, P., Hern-Anderson, D., Ranieri, J. & Schmidt, C. E. 2001 Vascular graft endothelialization: comparative analysis of canine and human endothelial cell migration on natural biomaterials. J. Biomed. Mater. Res. 56, 545-555. (doi:10.1002/1097-4636(20010915)56:4〈545:: AID-JBM1126〉3.0. CO;2-V)
85. Dollé, J., Rezvan, A., Allen, F. D., Lazarovici, P. & Lelkes, P. I. 2005 Nerve growth factor-induced migration of endothelial cells. J. Pharmacol. Exp. Ther. 315, 1220-1227. (doi:10.1124/jpet.105.093252)
86. Koh, W., Stratman, A. N., Sacharidou, A. & Davis, G. E. 2008 Chapter 5 in vitro three dimensional collagen matrix models of endothelial lumen formation during vaculogenesis and angiogenesis. Methods Enzymol. 433, 83-101. (doi:10.1016/S0076-6879(08)02005-3)
87. Cai, W., Wang, M., Moore, P. K., Jin, H., Yao, T. & Zhu, Y. 2007 The novel proangiogenic effect of hydrogen sulfide is dependent on Akt phosphorylation. Cardiovasc. Res. 76, 29-40. (doi:10.1016/j.cardiores.2007.05. 026)
88. Yasuda, M., Ohzeki, Y., Shimizu, S., Naito, S., Ohtsuru, A., Yamamoto, T. & Kuroiwa, Y. 1999 Stimulation of in vitro angiogenesis by hydrogen peroxide and the relation with ETS-1 in endothelial cells. Life Sci. 64, 249-258. (doi:10.1016/S0024-3205(98)00560-8)
89. Stadtman, E. R. & Berlett, B. S. 1991 Fenton chemistry. amino acid oxidation. J. Biol. Chem. 266, 17 201-17 211.
90. Violand, B. N. & Siegel, N. R. 2000 Protein and peptide chemical and physical stability. In Peptide and protein drug analysis (ed. R. E. Reid), pp. 257-284. Boca Raton, FL: CRC Press.
91. Gebicki, S. & Gebicki, J. M. 1993 Formation of peroxides in amino acids and proteins exposed to oxygen free radicals. Biochem. J. 289, 743-749. (Pubitemid 23074957)
92. Davies, K. J. A., Delsignore, M. E. & Lin, S. W. 1987 Protein damage and degradation by oxygen radicals II. Modification of amino acids. J. Biol. Chem. 262, 9902-9907.
93. Wong, C. M., Cheema, A. K., Zhang, L. & Suzuki, Y. J. 2008 Protein carbonylation as a novel mechanism in redox signaling. Circ. Res. 102, 310-318. (doi:10.1161/CIRCRESAHA.107.159814)
94. Suzuki, Y. J., Carini, M. & Butterfield, D. A. 2010 Protein carbonylation. Antioxid. Redox Signal. 12, 323-325. (doi:10.1089/ars.2009.2887)
95. Bienert, G., Moller, A., Kristiansen, K., Schulz, A., Moller, I., Schjoerring, J. & Jahn, T. 2007 Specific aquaporins facilitate the diffusion of hydrogen peroxide across membranes. J. Biol. Chem. 282, 1183-1192. (doi:10.1074/jbc.M603761200)
96. Bienert, G. P., Schjoerring, J. K. & Jahn, T. P. 2006 Membrane transport of hydrogen peroxide. Biochim. Biophys. Acta 1758, 994-1003. (doi:10.1074/jbc.M603761200)
97. Slater, T. F. 1984 Free-radical mechanisms in tissue injury. Biochem. J. 222, 1-15.
98. Finkel, T. 1999 Signal transduction by reactive oxygen species in non-phagocytic cells. J. Leukoc. Biol. 65, 337-340. (Pubitemid 29109705)
99. Finkel, T. 2000 Redox-dependent signal transduction. FEBS Lett. 476, 52-54. (doi:10.1016/S0014-5793(00)01669-0)
100. Salganik, R. I. 2001 The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population. J. Am. Coll. Nutr. 20, S464-S472.
101. 2+-ATPase. Bios 57, 63-74.
102. Jain, S. K. 1984 The accumulation of malonyldialdehyde, a product of fatty acid peroxidation, can disturb aminophospholipid organization in the membrane bilayer of human erythrocytes. J. Biol. Chem. 259, 3391-3394. (Pubitemid 14170059)
103. McNeil, P. L. & Steinhardt, R. A. 1997 Loss, restoration and maintenace of plasma membrane integrity. J. Cell Biol. 137, 1-4. (doi:10.1083/jcb.137.1.1)
104. Cho, K. S., Lee, E. H., Choi, J. S. & Joo, C. K. 1999 Reactive oxygen species-induced apoptosis and necrosis in bovine corneal endothelial cells. Invest. Ophthalmol. Vis. Sci. 40, 911-919. (Pubitemid 29153257)
105. Simon, H. U., Haj-Yehia, A. & Levi-Schaffer, F. 2000 Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5, 415-418. (doi:10.1023/A:1009616228304)
106. Muthukrishnan, L., Warder, E. & McNeil, P. L. 1991 Basic fibroblast growth factor is efficiently released from a cytosolic storage site through plasma membrane disruptions of endothelial cells. J. Cell Physiol. 148, 1-16. (doi:10.1002/jcp.1041480102)
107. McNeil, P. L., Muthukrishnan, L., Warder, E. & D'Amore, P. A. 1989 Growth factors are released by mechanically wounded endothelial cells. J. Cell Biol. 109, 811-822. (doi:10.1083/jcb.109.2.811)
108. Yu, Q. C. & McNeil, P. L. 1992 Transient disruptions of aortic endothelial cell plasma membranes. Am. J. Pathol. 141, 1349-1360. (Pubitemid 23002620)
109. Bourguignon, G. & Bourguignon, L. 1987 Electric stimulation of protein and DNA synthesis in human fibroblasts. FASEB J. 1, 398-402. (Pubitemid 18033760)
110. Kataoka, Y., Murley, J. S., Baker, K. L. & Grdina, D. J. 2007 Relationship between phosphorylated histone H2AX formation and cell survival in human microvascular endothelial cells (HMEC) as a function of ionizing radiation exposure in the presence or absence of thiol-containing drugs. Radiat. Res. 168, 106-114. (doi:10.1667/RR0975.1)
111. Annex, B. & Simons, M. 2005 Growth factor-induced therapeutic angiogenesis in the heart: protein therapy. Cardiovasc. Res. 65, 649-655. (doi:10.1016/j.cardiores.2004.09.004)
112. Roche, M., Rondeau, P., Singh, N. R., Tarnus, E. & Bourdon, E. 2008 The antioxidant properties of serum albumin. FEBS Lett. 582, 1783-1787. (doi:10.1016/j.febslet.2008.04.057)